CLINAM 2012

Dear Nanomedcine Community

The updated Full Preliminary Programme of the European Conference for Clinical Nanomedicine is now online under http://www.clinam.org/images/stories/pdf/conference.pdf

We hope to meet you in Basel

CLINAM 5/12 with ETPN

European Summit for Clinical Nanomedicine

Basel, Switzerland, Monday, May 7, 09.00 h – Wednesday, May 9, 2012, 17.00 h

Updated Full Preliminary Programme (17.2.2011)

· 5^th European CLINAM Conference for Clinical Nanomedicine:
· 3^rd ETP Nanomedicine Brokerage Session
· 2^nd ETP Nanomedicine Policy – Industry Table
· 3^rd EU FP7 Nanomedicine Projects Meeting
· 5^th Nanomedicine University Village & Foyer Exhibition

congress center │basel Messeplatz 21, Basel, Switzerland

CALL FOR PAPERS&POSTERS

Scientific Conference Committee

Prof. Dr. med. Patrick Hunziker, Deputy Head of the Intensive Care Clinic, University Hospital Basel; President of the European Society for Nanomedicine, Basel (CH) (Medical Chair) Prof. Dr. Yechezkel Barenholz, Head, Lab of Membrane and Liposome Research Department of Biochemistry, Hebrew University - Hadassah Medical School, Jerusalem (IL) (Scientific Chair) Beat Löffler, MA, CEO of the European Foundation for Clinical Nanomedicine (CLINAM), Basel (CH) (Programme Chair) Dr. rer. nat. Andreas Jordan, CSO, MagForce Nanotechnologie AG, Berlin (D) Dr. Sc. nat. Ruth Schmid, Chief Business Developer SINTEF Materials and Chemistry Synthesis and Properties Polymer Particles and Surface Chemistry Trondheim (N) Prof. Dr. Gert Storm, Institute for Pharmaceutical Sciences, Utrecht University, Utrecht (NL) Prof. Dr. Marisa Papaluca Amati, Head of Scientific Support and Projects, European Medicines Agency, London (UK) Prof. Dr. med. Janos Szebeni, Director, Nanomedicine Research and Education Center, Bay Zoltan Ltd/Semmelweis/Miskolc Universities, Budapest (H) Prof. Dr. med. Christoph Alexiou, Head Division for Experimental Oncology and Nanomedicine at the Department of Oto-Rhino-Laryngology, Head and Neck Surgery, University Hospital Erlangen (D) Prof. Dr. Claus-Michael Lehr, Head, Department of Drug Delivery (DDEL), Helmholtz-Institute for Pharmaceutical Research Saarland (HIPS), Saarland University, Saarbrücken (D) Patrick Boisseau, CEA-Léti, Head of the Business Development Nanomedicine; Board-member of the European Technology Platform on Nanomedicine Chair, WG Nanodiagnostics, Grenoble (F) Prof. Dr. Viola Vogel, Department of Materials Laboratory for Biologically Oriented Materials, ETH Zürich, Zürich (CH)